[Effect of traxanox on antibody formation in BALB/c mice]. 1984

M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa

The production of spleen- and thymus-rosette forming cells (RFC) in BALB/c mice 4 days after immunization with 5 X 10(8) sheep red blood cells (SRBC) was inhibited by traxanox at doses of 10-30 mg/kg, p.o. This agent (100 mg/kg, p.o.) suppressed the 19S hemagglutinin titer and elevated the 7S hemagglutinin titer. The transfer of spleen-RFC of thymus-RFC into syngeneic recipient mice 4 days after immunization with SRBC increased the production of spleen hemolytic plaque forming cells (HPFC). This increase was abolished by the transfer of spleen-RFC obtained from mice treated with traxanox (30 mg/kg, p.o.), but not by the transfer of spleen-RFC treated with anti-Lyt 2.2 antiserum and complement. The viability of the spleen-RFC in mice treated with traxanox was decreased by treatment with anti-Lyt 2.2 antiserum and complement. Traxanox (3-30 mg/kg, p.o) significantly increased the inhibition of HPFC, spleen-RFC and thymus-RFC production by Concanavalin A at a dose of 50 micrograms/mouse. This agent (3-30 mg/kg, p.o) inhibited the production of HPFC, spleen-RFC and thymus-RFC in mice 4 days after the secondary immunization. These results suggest that traxanox may inhibit antibody production via the induction of Lyt 2.2 positive cells (suppressor T cells).

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
January 1988, International journal of tissue reactions,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
January 1980, International archives of allergy and applied immunology,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
April 1995, Journal of endodontics,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
January 1984, Archivum immunologiae et therapiae experimentalis,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
April 2015, Wei sheng wu xue bao = Acta microbiologica Sinica,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
September 1985, Journal of immunology (Baltimore, Md. : 1950),
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
March 2003, International immunopharmacology,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
April 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
September 2013, International immunopharmacology,
M Hisadome, and K Goto, and M Terasawa, and Y Kadobe, and C Abe, and Y Shiokawa
August 1999, The Journal of endocrinology,
Copied contents to your clipboard!